- Alibaba and Amazon dominate global e-commerce
- ChineseInvestors.com just successfully launched first hemp-infused skin care products in China
- Company aims to dominate market
When considering e-commerce, Amazon is usually the first name that pops up. However, Alibaba is, by many metrics, both China’s and the world’s largest online e-commerce company. Alibaba commands about 50% market share of business-to-consumer e-commerce in China, while Amazon is the e-commerce elephant in the United States, garnering about 44% of e-commerce sales. To achieve maximum market penetration and global exposure, ChineseInvestors.com, Inc. (OTCQB: CIIX) just successfully launched its OptHemp Product Line on both Amazon and Alibaba.
Initially launched as a specialized investment services company providing real-time commentary, analysis and educational related services in the Chinese language, ChineseInvestors.com’s long-term quest for value-add opportunities led it to stake out a position in the explosive new medical CBD market. With nearly two decades of brand recognition, a 100,000+ user base and a target market of nearly two billion Chinese-speaking people, ChineseInvestors.com launched into the CBD market in 2016. Simultaneously, the company continued to expand its core investor education business, adding a Chinese speakers-targeted daily video telecast on cryptocurrencies, and recently announce a 186 percent jump in sales for 1Q2018 in its investor relations division.
In addition to nurturing its legacy business to record growth, ChineseInvestors.com has established a significant footprint in the global CBD market in only one year. The company’s latest foray into the CBD market may be its boldest and, potentially, most profitable endeavor to date, as it aims to dominate the entire hemp-infused skin care products market throughout China. The company retails its hemp oil-based cannabidiol (CBD) products on Alibaba and Amazon under the “OptHemp” brand through its wholly-owned subsidiaries, CBD Biotechnology Co. Ltd. and ChineseHempOil.com, Inc. As indication of consumer acceptance, the company’s “CBD Magic Hemp Series” generated 40,000 views and registered over 91 units purchased just minutes after launch. Commenting on the overwhelming response to its product launch, ChineseInvestors.com CEO Warren Wang stated that it “solidifies our belief that Chinese consumers recognize that the anti-inflammatory agents and anti-oxidants contained in hemp-extract can have positive effects on the skin.”
In business for nearly two decades and with a track record of stellar revenue growth and strategic diversification, the company is primed to capitalize on its position as the first to market in China with hemp-infused skin care products through its partnerships with global e-commerce behemoths. These factors certainly suggest strong upside potential for ChineseInvestors.com.
For more information, visit the company’s website at www.ChineseInvestors.com
More from CannabisNewsWire
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
